Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
JAMA Oncology
|
December 23, 2021
Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
Robert J Motzer, Thomas Powles, Michael B Atkins, et al.
Nature Communications
|
December 3, 2025
Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations
Tianshi Lu, Habib Hamidi, Mark A Socinski, et al.
Blood Neoplasia
|
June 22, 2026
Single-agent mosunetuzumab in older or unfit patients with previously untreated DLBCL: results of a phase 1/2 trial
Adam J Olszewski, Abraham Avigdor, Sunil Babu, et al.
Cancer Cell
|
November 6, 2020
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade
Robert J Motzer, Romain Banchereau, Habib Hamidi, et al.
The Journal of Biological Chemistry
|
December 4, 2014
Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression
Brian G Drew, Habib Hamidi, Zhenqi Zhou, et al.
Cell Reports. Medicine
|
November 29, 2025
Molecular subtypes of hepatocellular carcinoma linked to liver cell lineages and clinical outcomes of combination immunotherapy
Yulei Wang, Yinghui Guan, Alexander R Abbas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 3, 2023
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial
Charles N Landen, Luciana Molinero, Habib Hamidi, et al.
Human Molecular Genetics
|
April 11, 2013
Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel
Mine S Cicek, Devin C Koestler, Brooke L Fridley, et al.
Cancer Cell
|
February 17, 2024
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
Barzin Y Nabet, Habib Hamidi, Myung Chang Lee, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 20, 2024
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial
Marina Y Konopleva, Monique Dail, Naval G Daver, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
JAMA Oncology
|
December 23, 2021
Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma
Robert J Motzer, Thomas Powles, Michael B Atkins, et al.
Nature Communications
|
December 3, 2025
Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations
Tianshi Lu, Habib Hamidi, Mark A Socinski, et al.
Blood Neoplasia
|
June 22, 2026
Single-agent mosunetuzumab in older or unfit patients with previously untreated DLBCL: results of a phase 1/2 trial
Adam J Olszewski, Abraham Avigdor, Sunil Babu, et al.
Cancer Cell
|
November 6, 2020
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade
Robert J Motzer, Romain Banchereau, Habib Hamidi, et al.
The Journal of Biological Chemistry
|
December 4, 2014
Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression
Brian G Drew, Habib Hamidi, Zhenqi Zhou, et al.
Cell Reports. Medicine
|
November 29, 2025
Molecular subtypes of hepatocellular carcinoma linked to liver cell lineages and clinical outcomes of combination immunotherapy
Yulei Wang, Yinghui Guan, Alexander R Abbas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 3, 2023
Influence of Genomic Landscape on Cancer Immunotherapy for Newly Diagnosed Ovarian Cancer: Biomarker Analyses from the IMagyn050 Randomized Clinical Trial
Charles N Landen, Luciana Molinero, Habib Hamidi, et al.
Human Molecular Genetics
|
April 11, 2013
Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel
Mine S Cicek, Devin C Koestler, Brooke L Fridley, et al.
Cancer Cell
|
February 17, 2024
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
Barzin Y Nabet, Habib Hamidi, Myung Chang Lee, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 20, 2024
Venetoclax and Cobimetinib in Relapsed/Refractory AML: A Phase 1b Trial
Marina Y Konopleva, Monique Dail, Naval G Daver, et al.
Page
of 5